Literature DB >> 25037083

Toxic myopathies.

Mamatha Pasnoor1, Richard J Barohn2, Mazen M Dimachkie2.   

Abstract

Muscle tissue is highly sensitive to many substances. Early recognition of toxic myopathies is important, because they potentially are reversible on removal of the offending drug or toxin, with greater likelihood of complete resolution the sooner this is achieved. Clinical features range from mild muscle pain and cramps to severe weakness with rhabdomyolysis, renal failure, and even death. The pathogenic bases can be multifactorial. This article reviews some of the common toxic myopathies and their clinical presentation, histopathologic features, and possible underlying cellular mechanisms.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Muscle tissue; Myopathy; Statins; Toxic myopathies

Mesh:

Substances:

Year:  2014        PMID: 25037083      PMCID: PMC4346323          DOI: 10.1016/j.ncl.2014.04.009

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  118 in total

Review 1.  Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?

Authors:  David W J Clark; Johanna Strandell
Journal:  Eur J Clin Pharmacol       Date:  2006-04-22       Impact factor: 2.953

2.  Myopathy after short term administration of procainamide.

Authors:  C A Lewis; N Boheimer; P Rose; G Jackson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-01

3.  Immunologic studies in cimetidine-induced nephropathy and polymyositis.

Authors:  A J Watson; M H Dalbow; I Stachura; J A Fragola; M F Rubin; R M Watson; E Bourke
Journal:  N Engl J Med       Date:  1983-01-20       Impact factor: 91.245

4.  Diffuse fasciitis with eosinophilia (shulman syndrome).

Authors:  Wiliam E Owens; Tulio E Bertorini; Hugh T Holt; Mariallan K Shadle
Journal:  J Clin Neuromuscul Dis       Date:  2004-12

Review 5.  Effects and side effects associated with the non-nutritional use of tryptophan by humans.

Authors:  John D Fernstrom
Journal:  J Nutr       Date:  2012-10-17       Impact factor: 4.798

6.  Demyelinating polyneuropathy in eosinophilia-myalgia syndrome.

Authors:  P D Donofrio; C Stanton; V S Miller; L Oestreich; D S Lefkowitz; F O Walker; E W Ely
Journal:  Muscle Nerve       Date:  1992-07       Impact factor: 3.217

Review 7.  The untoward effects of steroid treatment on the musculoskeletal system and what to do about them.

Authors:  J R Hollister
Journal:  J Asthma       Date:  1992       Impact factor: 2.515

8.  Chloroquine neuromyotoxicity. Clinical and pathologic perspective.

Authors:  M L Estes; D Ewing-Wilson; S M Chou; H Mitsumoto; M Hanson; E Shirey; N B Ratliff
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965

9.  Severe hydroxychloroquine myopathy.

Authors:  Hoda Abdel-Hamid; Chester V Oddis; David Lacomis
Journal:  Muscle Nerve       Date:  2008-09       Impact factor: 3.217

10.  Statin-associated muscular and renal adverse events: data mining of the public version of the FDA adverse event reporting system.

Authors:  Toshiyuki Sakaeda; Kaori Kadoyama; Yasushi Okuno
Journal:  PLoS One       Date:  2011-12-20       Impact factor: 3.240

View more
  14 in total

Review 1.  Diagnostic Imaging of Inflammatory Myopathies: New Concepts and a Radiological Approach.

Authors:  Júlio Brandão Guimarães; Marcelo A Nico; Alípio G Omond; Laís Uyeda Aivazoglou; Rafael Baches Jorge; Edmar Zanoteli; Artur R C Fernandes
Journal:  Curr Rheumatol Rep       Date:  2019-02-14       Impact factor: 4.592

2.  Delayed rhabdomyolysis secondary to anabolic-androgenic steroid use.

Authors:  Amelia Benjamin; Alex Anderson; Sanja Zrelec
Journal:  Clin Med (Lond)       Date:  2020-11       Impact factor: 2.659

Review 3.  Statin-Associated Muscle Adverse Events: Update for clinicians.

Authors:  Maha A Al-Mohaissen; Martha J Ignaszewski; Jiri Frohlich; Andrew P Ignaszewski
Journal:  Sultan Qaboos Univ Med J       Date:  2016-11-30

Review 4.  Development and application of human skeletal muscle microphysiological systems.

Authors:  George A Truskey
Journal:  Lab Chip       Date:  2018-10-09       Impact factor: 6.799

Review 5.  Antimalarial myopathy in a systemic lupus erythematosus patient with quadriparesis and seizures: a case-based review.

Authors:  Kashif Jafri; Hengameh Zahed; Katherine D Wysham; Sarah Patterson; Amber L Nolan; Matthew D Bucknor; R Krishna Chaganti
Journal:  Clin Rheumatol       Date:  2017-02-24       Impact factor: 3.650

Review 6.  Differential diagnosis of idiopathic inflammatory myopathies in adults - the first step when approaching a patient with muscle weakness.

Authors:  Piotr Szczęsny; Katarzyna Świerkocka; Marzena Olesińska
Journal:  Reumatologia       Date:  2018-10-31

7.  Colchicine Myopathy: A Case Series Including Muscle MRI and ABCB1 Polymorphism Data.

Authors:  Mehul Gupta; Ana Nikolic; Denise Ng; Kristina Martens; Hamid Ebadi; Sameer Chhibber; Gerald Pfeffer
Journal:  Front Neurol       Date:  2019-05-24       Impact factor: 4.003

Review 8.  Zebrafish as a Model for the Study of Lipid-Lowering Drug-Induced Myopathies.

Authors:  Magda Dubińska-Magiera; Marta Migocka-Patrzałek; Damian Lewandowski; Małgorzata Daczewska; Krzysztof Jagla
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

9.  Disability, social functioning and school inclusion among older children and adolescents living with HIV in Zimbabwe.

Authors:  Ruramayi Rukuni; Grace McHugh; Edith Majonga; Katharina Kranzer; Hilda Mujuru; Shungu Munyati; Kusum Nathoo; Celia L Gregson; Hannah Kuper; Rashida A Ferrand
Journal:  Trop Med Int Health       Date:  2017-12-26       Impact factor: 2.622

10.  Necrotizing Autoimmune Myopathy: Clinicopathologic Study from a Single Tertiary Care Centre.

Authors:  Sobiya Mahnaz Ayesha; A K Meena; Navatha Vangala; Liza Rajasekhar; Subhash Kaul; Rupam Borgahain; Megha S Uppin
Journal:  Ann Indian Acad Neurol       Date:  2018 Jan-Mar       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.